Vida Ventures Advisors

Latest statistics and disclosures from Vida Ventures Advisors's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are PRAX, KNTE, KRON, DYN, ALLO, and represent 94.65% of Vida Ventures Advisors's stock portfolio.
  • Added to shares of these 3 stocks: PRAX (+$162M), KNTE (+$109M), KRON (+$83M).
  • Started 3 new stock positions in PRAX, KRON, KNTE.
  • Vida Ventures Advisors was a net buyer of stock by $354M.
  • Vida Ventures Advisors has $487M in assets under management (AUM), dropping by 205.18%.
  • Central Index Key (CIK): 0001831423

Tip: Access up to 7 years of quarterly data

Positions held by Vida Ventures Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Vida Ventures Advisors

Companies in the Vida Ventures Advisors portfolio as of the December 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Praxis Precision Medicines Common Stock (PRAX) 33.2 $162M NEW 2.9M 55.02
Kinnate Biopharma Common Stock (KNTE) 22.4 $109M NEW 2.7M 39.78
Kronos Bio Common Stock (KRON) 17.0 $83M NEW 2.8M 29.87
Dyne Therapeutics Common Stock (DYN) 12.8 $62M 3.0M 21.00
Allogene Therapeutics Common Stock (ALLO) 9.3 $45M 1.8M 25.24
Oyster Point Pharma Common Stock (OYST) 3.0 $15M 779k 18.82
Homology Medicines Common Stock (FIXX) 1.8 $8.7M 771k 11.29
Assembly Biosciences Common Stock (ASMB) 0.6 $2.7M 450k 6.05

Past Filings by Vida Ventures Advisors

SEC 13F filings are viewable for Vida Ventures Advisors going back to 2020